Back to Search
SONJA LINN, PH.D.
PH.D.
Counseling Psychologist
NPI: 1477722973Individual
Specialties, Licenses & Credentials
Counseling PsychologistPrimary
Psychologist — Counseling
Code: 103TC1900X
PSY1000207(DC)
Research & Publications (20)
The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment.
PMID 19622588·Ann Oncol·2010
4-observational
The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy.
PMID 19514094·Psychooncology·2010
8-other
Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
PMID 18777410·Acta Oncol·2009
4-observational
Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer.
PMID 18991335·J Pathol·2009
4-observational
Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics.
PMID 19126254·Int J Technol Assess Health Care·2009
8-other
Non-Hodgkin Lymphoma (NHL) linkage with residence near heavy roads--a case study from Haifa Bay, Israel.
PMID 19081284·Health Place·2009
8-other
Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.
PMID 19353633·J Pathol·2009
8-other
Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry.
PMID 19589736·J Chromatogr B Analyt Technol Biomed Life Sci·2009
4-observational
Validation of 70-gene prognosis signature in node-negative breast cancer.
PMID 18819002·Breast Cancer Res Treat·2009
4-observational
Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapy.
PMID 19095215·Am J Surg·2009
4-observational
Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
PMID 18311582·Breast Cancer Res Treat·2009
4-observational
Burkitt lymphoma in children: the Israeli experience.
PMID 19648792·J Pediatr Hematol Oncol·2009
4-observational
[Evaluation of ergonomic conditions of video display terminal operators in a general hospital].
PMID 18814515·Harefuah·2008
8-other
[The effect of hormone therapy on cognitive function in patients with breast cancer].
PMID 18389880·Ned Tijdschr Geneeskd·2008
6-review
Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
PMID 18708938·Am J Surg Pathol·2008
8-other
[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
PMID 19055260·Ned Tijdschr Geneeskd·2008
8-other
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
PMID 18042430·Lancet Oncol·2007
4-observational
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
PMID 17936563·Cancer Cell·2007
3-trial
Treating the genetic make-up of breast cancer: a new fashion?
PMID 17725409·Expert Rev Anticancer Ther·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2440 M ST NW, SUITE 411
WASHINGTON, DC 20037 - Phone
- (202) 887-8088
Quick Facts
- NPI
- 1477722973
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile